Orikami enables personalized healthcare by maximizing data value.


Orikami is on a mission to improve 100 million lives before 2030 by enabling personalized healthcare

Orikami Contact

Orikami enables personalized healthcare.

Orikami is a Dutch MedTech organization. We are specialized in applied data science. We develop and implement digital biomarkers to enable personalized healthcare for people with chronic diseases.


Our Mission

Our mission - to improve 100 million lives before 2030 by enabling personalized healthcare.

We believe health data is underutilized. We use real-world patient data to enable personalized healthcare paths for our clients to improve their quality of life. Therefore, we develop digital biomarkers.

Our solutions deliver better outcomes and affordable healthcare.

VALUE of Digital Biomarkers

Clinical validated digital biomarkers provide objective data that provides clinically significant results. This enables decision support to clinicians and will optimize patients’ health paths. This is needed to innovate healthcare and increase the efficiency of the healthcare ecosystems.

Clients and partners we work with


PRESS RELEASE: Orikami brings in new investors

Nijmegen, May 31, 2021 As of May 2021, CbusineZ will join Orikami Group BV, alongside existing investor Healthy.Capital. Both investors enable Orikami to roll out the product MS sherpa to clinical practice and also accelerate…

Read more

Orikami Blogs

Our colleagues regularly dive into interesting and difficult topics to write down in detail in a blog. All our blogs are collected on this website.

Read more

Interested in our personalized healthcare solutions?

  • This field is for validation purposes and should be left unchanged.